Schedule 13G ownership disclosure
HORIZON PHARMA, INC.
Security class unavailable · CUSIP: 44047T109
Event date: 2013-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,296,728
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-14-033384
- Form type
- SC 13G
- Filer
- Horizon Therapeutics Public Ltd Co
- CIK
- CIK 1492426
- Filed
- May 01, 2014
- Reporting period
- Dec 31, 2013
- Description
- Schedule 13G beneficial ownership